Glaxosmithkline Share News (GSK)

Glaxosmithkline Information

Buy GSK Shares
Add GSK to Watchlist
Add GSK to Alert

Share Price Information for Glaxosmithkline (GSK)

Share Price is delayed by 15 minutes

Get Live Data

Share Price: 1,766.50

Bid: 1,766.00

Ask: 1,766.50

Change: 36.50 (2.11%)

Spread: 0.50 (0.028%)

Open: 1,735.50

High: 1,766.50

Low: 1,735.00

Prev. Close: 1,730.00

Last checked at -

UK BROKER RATINGS: Goldman Cuts Antofagasta, Raises Anglo American

Fri, 23rd Jan 2015 09:52

LONDON (Alliance News) - The following UK shares received analyst recommendations Friday morning and Thursday afternoon:
----------
FTSE 100
----------
SOCGEN RAISES REED ELSEVIER PRICE TARGET TO 1275 (1105) PENCE - 'BUY'
----------
SOCGEN RAISES WPP PRICE TARGET TO 1685 (1530) PENCE - 'BUY'
----------
SOCGEN RAISES PEARSON PRICE TARGET TO 1220 (1105) PENCE - 'HOLD'
----------
SOCGEN RAISES ITV PRICE TARGET TO 240 (220) PENCE - 'HOLD'
----------
SOCGEN RAISES SKY PLC PRICE TARGET TO 1110 (1045) PENCE - 'BUY'
----------
BERENBERG CUTS CENTRICA PRICE TARGET TO 300 (370) PENCE - 'BUY'
----------
BERNSTEIN CUTS HSBC PRICE TARGET TO 660 (800) PENCE - 'OUTPERFORM'
----------
BERENBERG RAISES ASTRAZENECA PRICE TARGET TO 4800 (4240) PENCE - 'HOLD'
----------
BERENBERG RAISES GLAXOSMITHKLINE PRICE TARGET TO 1620 (1540) PENCE - 'HOLD'
----------
BERENBERG CUTS INTERTEK PRICE TARGET TO 2375 (2800) PENCE - 'HOLD'
----------
BARCLAYS RAISES ST JAMES'S PLACE PRICE TARGET TO 939 (916) PENCE - 'OVERWEIGHT'
----------
TRADERS: GOLDMAN CUTS ANTOFAGASTA TO 'NEUTRAL' ('BUY')
----------
JPMORGAN CUTS ANTOFAGASTA PRICE TARGET TO 710 (755) PENCE - 'NEUTRAL'
----------
TRADERS: GOLDMAN RAISES ANGLO AMERICAN TO 'NEUTRAL' ('SELL')
----------
JPMORGAN CUTS ANGLO AMERICAN PRICE TARGET TO 1120 (1340) PENCE - 'UNDERWEIGHT'
----------
UBS CUTS EXPERIAN TO 'NEUTRAL' ('BUY')
----------
CITIGROUP RAISES ST JAMES'S PLACE PRICE TARGET TO 1000 (870) PENCE - 'BUY'
----------
NUMIS RAISES ST JAMES'S PLACE PRICE TARGET TO 980 (850) PENCE - 'ADD'
----------
CITIGROUP CUTS WEIR GROUP PRICE TARGET TO 1750 (1900) PENCE - 'NEUTRAL'
----------
MORGAN STANLEY RAISES IAG PRICE TARGET TO 7.50 (6.60) EUR - 'OVERWEIGHT'
----------
NUMIS RAISES WHITBREAD PRICE TARGET TO 5600 (5150) PENCE - 'ADD'
----------
JPMORGAN RAISES WHITBREAD PRICE TARGET TO 5250 (5000) PENCE - 'OVERWEIGHT'
----------
JPMORGAN RAISES COMPASS GROUP PRICE TARGET TO 1150 (1050) PENCE - 'NEUTRAL'
----------
JPMORGAN RAISES FRESNILLO PRICE TARGET TO 1190 (1110) PENCE - 'OVERWEIGHT'
----------
JPMORGAN RAISES INTERCONTINENTAL HOTELS TARGET TO 2600 (2200) PENCE - 'NEUTRAL'
----------
JPMORGAN RAISES WHITBREAD PRICE TARGET TO 5250 (5000) PENCE - 'OVERWEIGHT'
----------
JPMORGAN CUTS BHP BILLITON PRICE TARGET TO 1550 (1870) PENCE - 'NEUTRAL'
----------
JPMORGAN CUTS RIO TINTO PRICE TARGET TO 3400 (3500) PENCE - 'OVERWEIGHT'
----------
FTSE 250
----------
JPMORGAN RAISES BETFAIR PRICE TARGET TO 1600 (1510) PENCE - 'OVERWEIGHT'
----------
NUMIS RAISES BALFOUR BEATTY TO 'ADD' ('HOLD') - TARGET 230 PENCE
----------
SOCGEN RAISES INFORMA TO 'BUY' ('HOLD') - TARGET 585 (500) PENCE
----------
UBS CUTS OXFORD INSTRUMENTS PRICE TARGET TO 950 (1300) PENCE - 'BUY'
----------
BERENBERG CUTS OXFORD INSTRUMENTS TO 'HOLD' ('BUY') - TARGET 950 (1360) PENCE

BARCLAYS CUTS OXFORD INSTRUMENTS PRICE TARGET TO 860 (1140) PENCE - 'EQUALWEIGHT'

JPMORGAN CUTS OXFORD INSTRUMENTS TARGET TO 1200 (1350) PENCE - 'OVERWEIGHT'

UBS CUTS RENTOKIL INITIAL TO 'SELL' ('NEUTRAL') - TARGET 112 PENCE
----------
UBS CUTS OPHIR ENERGY PRICE TARGET TO 150 (230) PENCE - 'NEUTRAL'
----------
BARCLAYS CUTS ELECTROCOMPONENTS PRICE TARGET TO 210 (229) PENCE - 'EQUALWEIGHT'
----------
BARCLAYS CUTS PREMIER FARNELL PRICE TARGET TO 188 (205) PENCE - 'EQUAL WEIGHT'
----------
TRADERS: JPMORGAN CUTS TELECITY GROUP TO 'NEUTRAL' ('OVERWEIGHT')
----------
TRADERS: MORGAN STANLEY CUTS MICHAEL PAGE TO 'EQUAL-WEIGHT' ('OVERWEIGHT')
----------
UBS CUTS MICHAEL PAGE TO 'NEUTRAL' ('BUY')
----------
EXANE BNP CUTS CRODA TO 'NEUTRAL' ('OUTPERFORM') - TARGET 2770 (2820) PENCE
----------
EXANE BNP CUTS ELEMENTIS TO 'NEUTRAL' ('OUTPERFORM') - TARGET 300 PENCE
----------
CITIGROUP RAISES HENDERSON GROUP PLC PRICE TARGET TO 246 (218) PENCE - 'BUY'
----------
MORGAN STANLEY RAISES HAYS PRICE TARGET TO 165 (160) PENCE - 'OVERWEIGHT'
----------
JPMORGAN CUTS TELECITY TO 'NEUTRAL' ('OVERWEIGHT') - TARGET 900 (925) PENCE
----------
JPMORGAN RAISES LADBROKES PRICE TARGET TO 110 (95) PENCE - 'UNDERWEIGHT'
----------
JPMORGAN RAISES PLAYTECH PRICE TARGET TO 635 (615) PENCE - 'NEUTRAL'
----------
JPMORGAN RAISES SSP GROUP PRICE TARGET TO 320 (310) PENCE - 'OVERWEIGHT'
----------
JPMORGAN CUTS KAZ MINERALS PRICE TARGET TO 335 (365) PENCE - 'OVERWEIGHT'
----------
JPMORGAN CUTS VEDANTA PRICE TARGET TO 530 (960) PENCE - 'NEUTRAL'
----------
MAIN MARKET AND AIM
----------
SOCGEN CUTS DAILY MAIL PRICE TARGET TO 720 (740) PENCE - 'SELL'
----------
JPMORGAN RAISES GEM DIAMONDS PRICE TARGET TO 290 (280) PENCE - 'OVERWEIGHT'
----------
JPMORGAN RAISES HOCHSCHILD MINING PRICE TARGET TO 130 (125) PENCE - 'NEUTRAL'
----------
JPMORGAN CUTS FERREXPO PRICE TARGET TO 80 (110) PENCE - 'NEUTRAL'
----------
JPMORGAN CUTS PETROPAVLOVSK PRICE TARGET TO 9 (10) PENCE - 'UNDERWEIGHT'
----------
By Arvind Bhunjun; arvindbhunjun@alliancenews.com; @ArvindBhunjun

Copyright 2015 Alliance News Limited. All Rights Reserved.

More News

1 Nov 2023 08:51

TOP NEWS: GSK ups guidance as boosted by Shingrix and Arexvy

(Alliance News) - GSK PLC on Wednesday hailed the performance of the world's first approved respiratory syncytial virus vaccine Arexvy, as it reported a rise in profit and revenue.

1 Nov 2023 08:50

LONDON MARKET OPEN: FTSE 100 up, FTSE 250 down as Aston Martin tumbles

(Alliance News) - Stock prices in London opened mixed on Wednesday, ahead of key central bank decisions, as investors were cheered by some strong updates from large-cap listings.

1 Nov 2023 07:40

LONDON BRIEFING: GSK raises annual guidance following Arexvy launch

(Alliance News) - Stocks in London are called higher on Wednesday, with the main focal point for the day being the upcoming US interest rate decision.

1 Nov 2023 07:27

GSK hikes guidance after strong third quarter

(Sharecast News) - GSK announced a robust third quarter on Wednesday, prompting an upgrade to its full-year guidance.

30 Oct 2023 09:01

IN BRIEF: GSK says Jemperli meets endpoint in endometrial cancer trial

GSK PLC - Brentford, west London-based pharmaceutical maker - Jemperli, whose generic name is dostarlimab, meets endpoint of overall survival in phase III Ruby trial on adult patients with primary advanced or recurrent endometrial cancer. Jemperli, combined with standard-of-care chemotherapy, followed by dostarlimab, demonstrated a "statistically significant and clinically meaningful benefit" to the patients in the trial.

30 Oct 2023 07:06

GSK's Jemperli sees success in endometrial cancer trial

(Sharecast News) - GSK reported encouraging outcomes from part one of the 'RUBY' phase three trial evaluating the efficacy of 'Jemperli', or dostarlimab, with standard chemotherapy for treating adult patients with advanced or recurrent endometrial cancer on Monday.

26 Oct 2023 09:19

TOP NEWS: GSK subsidiary ViiV receives HIV drug approval in China

(Alliance News) - GSK PLC on Thursday said its subsidiary ViiV Healthcare has received marketing authorisation in China for its cabotegravir treatment, marketed as Vocabria.

26 Oct 2023 07:02

GSK HIV injection regimen gets approval in China

(Sharecast News) - GSK announced on Thursday that its majority-owned HIV specialist subsidiary ViiV has received approval from the National Medical Products Administration (NMPA) of China for an injection regimen.

25 Oct 2023 16:01

UK earnings, trading statements calendar - next 7 days

Thursday 26 October
Bank of Ireland Group PLC	Trading Statement
Bloomsbury Publishing PLC	Half Year Results
Botswana Diamonds PLC	Trading Statement
C&C Group PLC	Half Year Results
e-Therapeutics PLC	Half Year Results
Financials Acquisition Corp	Trading Statement
GCP Infrastructure Investments Ltd	Trading Statement
HarbourVest Global Private Equity Ltd	Half Year Results
Hummingbird Resources PLC	Trading Statement
Hunting PLC	Trading Statement
Inchcape PLC	Trading Statement
International Personal Finance PLC	Trading Statement
PPHE Hotel Group Ltd	Trading Statement
Renishaw PLC	Trading Statement
Standard Chartered PLC	Q3 Results
Unilever PLC	Trading Statement
WPP PLC	Trading Statement
Friday 27 October
International Consolidated Airlines Group SA	Q3 Results
NatWest Group PLC	Q3 Results
Monday 30 October
Airtel Africa PLC	Half Year Results
Computacenter PLC	Trading Statement
Glencore PLC	Trading Statement
HSBC Holdings PLC	Q3 Results
Lok'n Store Group PLC	Full Year Results
Pearson PLC	Trading Statement
Tuesday 31 October
BP PLC	Q3 Results
Coca-Cola HBC AG	Trading Statement
Elementis PLC	Trading Statement
essensys PLC	Full Year Results
Georgia Capital PLC	Q3 Results
Grit Real Estate Income Group Ltd	Full Year Results
RHI Magnesita NV	Trading Statement
Spectris PLC	Q3 Results
TP ICAP Group PLC	Trading Statement
UP Global Sourcing Holdings PLC	Full Year Results
Wednesday 1 November
Asos PLC	Full Year Results
Aston Martin Lagonda Global Holdings PLC	Q3 Results
Beximco Pharmaceuticals Ltd	Full Year Results
GSK PLC	Q3 Results
Next PLC	Trading Statement
Smurfit Kappa Group PLC	Trading Statement
Weir Group PLC	Trading Statement

Copyright 2023 Alliance News Ltd. All Rights Reserved.

25 Oct 2023 09:35

GSK says RSV jab shows promising response in adults aged 50 to 59

(Alliance News) - GSK PLC on Wednesday said a trial found its respiratory syncytial virus vaccine Arexy delivered an immune response in adults aged 50 to 59.

25 Oct 2023 07:27

GSK hails success in US RSV vaccine trial

(Sharecast News) - Pharma giant GSK has announced positive preliminary results from a trial of its Arexvy vaccine to treatment respiratory syncytial virus (RSV) disease for a younger patient population in the US.

16 Oct 2023 08:09

TOP NEWS: GSK receives positive EU opinion on Jemperli for cancer

(Alliance News) - GSK PLC on Monday said its monoclonal antibody Jemperli is closer to becoming the first new frontline treatment option in the EU in decades for a certain form of endometrial cancer.

16 Oct 2023 07:44

LONDON BRIEFING: Hipgnosis pulls interim dividend on lower royalties

(Alliance News) - The FTSE 100 is likely to open higher on Monday, benefitting from higher oil and gas prices, while fears of escalating regional conflict in the Middle East damp risk sentiment elsewhere.

16 Oct 2023 07:16

GSK nears green light for Jemperli usage in Europe

(Sharecast News) - Pharma giant GSK has announced that European experts recommended the approval of its Jerperli drug for the treatment of a specific type of endometrial cancer - paving the way for marketing authorisation by the continent's regulatory body.

11 Oct 2023 11:51

GSK settles California Zantac lawsuit

(Sharecast News) - GSK has agreed to settle another lawsuit concerning its discontinued heartburn treatment Zantac, the drugs giant confirmed on Wednesday.

Latest Share Chat

Glaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UK BROKER RATINGS: Goldman Cuts Antofagasta, Raises Anglo American

Login to your account

Quickpicks are a member only feature

Login to your account